Veracyte Inc logo

Veracyte Inc

NAS:VCYT (USA)  
$ 21.58 +0.48 (+2.27%) 11:09 PM EST
At Loss
P/B:
1.51
Volume:
947.18K
Avg Vol (2M):
610.09K
Also Trade In:
Volume:
947.18K
At Loss
Avg Vol (2M):
610.09K

Business Description

Description
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others.
Name Current Vs Industry Vs History
Cash-To-Debt 17.14
Equity-to-Asset 0.94
Debt-to-Equity 0.01
Debt-to-EBITDA -0.26
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 13.17
Distress
Grey
Safe
Beneish M-Score -2.76
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 34.88
9-Day RSI 34.71
14-Day RSI 37.09
6-1 Month Momentum % 1.69
12-1 Month Momentum % 10.3

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.66
Quick Ratio 4.4
Cash Ratio 3.53
Days Inventory 46.03
Days Sales Outstanding 42.77
Days Payable 42.63

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -8
Shareholder Yield % 0.2

Financials (Next Earnings Date:2024-05-03 Est.)

VCYT's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:VCYT

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Veracyte Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 361.051
EPS (TTM) ($) -1.03
Beta 1.87
Volatility % 38.92
14-Day RSI 37.09
14-Day ATR ($) 1.025667
20-Day SMA ($) 22.9935
12-1 Month Momentum % 10.3
52-Week Range ($) 19.52 - 30.52
Shares Outstanding (Mil) 75.07

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Veracyte Inc Filings

Filing Date Document Date Form
No Filing Data

Veracyte Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Veracyte Inc Frequently Asked Questions

What is Veracyte Inc(VCYT)'s stock price today?
The current price of VCYT is $21.58. The 52 week high of VCYT is $30.52 and 52 week low is $19.52.
When is next earnings date of Veracyte Inc(VCYT)?
The next earnings date of Veracyte Inc(VCYT) is 2024-05-03 Est..
Does Veracyte Inc(VCYT) pay dividends? If so, how much?
Veracyte Inc(VCYT) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1